Adding Blenrep to standard therapy prolonged progression-free survival in patients with relapsed or refractory multiple ...

GSK plc (NYSE:GSK) has strengthened its market outlook following major regulatory milestones. The U.S. FDA’s recent approval ...

Who doesn’t love a comeback story? Certainly not GSK, which has found a way to resuscitate its cancer treatment Blenrep as a ...

GSK (LSE:GSK) recently received FDA approval for Nucala for COPD treatment, potentially enhancing its market presence.

CHMP gives positive opinions for new drugs from GSK, Roche & SpringWorks, including GSK's Blenrep, Roche's Itovebi & ...

GSK stock dips 0.6% after six-session gain streak. EU panel backs Blenrep for multiple myeloma, while FDA expands asthma ...

A total of 1,046 measles cases have been reported in the U.S., according to the latest CDC data. Confirmed cases have been found in 30 states. So far this year, there have been 14 reported outbreaks, ...

The FTSE 100 index closed down 21.29 points, 0.2%, at 8,717.97. The FTSE 250 ended down 90.94 points, 0.4%, at 20,708.72, and the AIM All-Share closed down 0.70 points, 0.1%, at 736.04. The Cboe UK ...